本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Clearmind Medicine, Inc.

0.9602
-0.1598-14.27%
成交量:50.29万
成交额:50.81万
市值:493.04万
市盈率:-0.74
高:1.05
开:1.03
低:0.9500
收:1.12
数据加载中...
2025/01/22

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/12/09

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/03/27

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/03/19

SEC问询函

Form CORRESP - Correspondence
2024/03/18

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/02/14

SEC问询函

Form CORRESP - Correspondence
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/07

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/02/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/01/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/27

SEC问询函

Form CORRESP - Correspondence
2023/09/14

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/09/13

SEC问询函

Form CORRESP - Correspondence
2023/09/06

SEC问询函

Form CORRESP - Correspondence
2023/09/05

SEC问询函

Form CORRESP - Correspondence
2023/09/05

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/07/27

SEC问询函

Form CORRESP - Correspondence
2023/07/26

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]